跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
AMCAL+ IBUPROFEN 200 LIQUID CAPSULES 200 mg blister pack - TGA Drug Approval Details
Approvals
/
TGA
/
AMCAL+ IBUPROFEN 200 LIQUID CAPSULES 200 mg blister pack
Approved
STANDARD
AMCAL+ IBUPROFEN 200 LIQUID CAPSULES 200 mg blister pack
Neo Health (OTC) Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
14a26d21adfc6f84
Company
Neo Health (OTC) Pty Ltd
Type
Standard
Approval Details
Approval Id
14a26d21adfc6f84
Product Name
AMCAL+ IBUPROFEN 200 LIQUID CAPSULES 200 mg blister pack
Artg Id
385454
Artg Name
AMCAL+ IBUPROFEN 200 LIQUID CAPSULES 200 mg blister pack
Sponsor
Neo Health (OTC) Pty Ltd
Company Detail Path
/organization/neo-health-otc-pty-ltd
Artg Date
2022-03-10
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
14a26d21adfc6f84
Type
Standard
Back to TGA Approvals
